A SHOWCASE AND CELEBRATION OF OUR
2024 GRADUATING STARTUPS

Join us on May 9 at NYU Stern School of Business for Endless Frontier Labs’ capstone event, Frontiers 2024. At Frontiers 2024, you’ll have a chance to explore the groundbreaking work of our newly graduated startups through a series of pitch presentations across life sciences, digital tech, and deep tech verticals, as well as a panel discussion featuring industry experts from our distinguished mentor network.

Register Here

PROGRAM

MAY 9, 2024 – 8:00a – 7:00p ET

Speaker announcements and more event news coming soon.

Breakfast and Welcome Address

Panels + Startup Pitches

Networking Lunch

Panels + Startup Pitches

Elizabeth Elting Fund Award and Reception

ELIZABETH ELTING VENTURE FUND

A fund for women-founded startups

Our mission is to empower brilliant women entrepreneurs around the world to bring forward inspired ideas that will create impactful change. We provide capital and access to some of the best scientific, entrepreneurial, and investment minds to support our mission.


2024 GRADUATES

 

4M Therapeutics

FUNDRAISING

4M Therapeutics is developing targeted therapies for neurological and psychiatric disorders using its living human brain cell drug discovery platform. The lead asset is safer and more potent than lithium, the current standard of care for bipolar disorder.
Akool

FUNDRAISING

Akool delivers commercial-quality video and image generation capabilities to create personalized brand experiences through its generative AI content platform.
Ambulero

FUNDRAISING

Ambulero is advancing new cell and gene therapy products to treat patients with advanced vascular disease and non-healing wounds, where the standard of care is often amputation.
Ataraxis AI

Ataraxis AI is developing prognostic and predictive digital diagnostic assays that integrate multi-modal data to deliver accurate, patient-specific predictions about therapeutic outcomes across several diseases, starting with early-stage breast cancer.
Atticus Pharma

Atticus Pharma is improving the bioavailability and effectiveness of topically applied drugs with its innovative Z-pod® sustained-release technology.
Avstera Therapeutics

FUNDRAISING

Avstera Therapeutics is a clinical-stage oncology company tackling key immunological challenges seen in the tumor microenvironment with its oral HDAC6 inhibitor for advanced cancer patients who fail to respond to existing therapies.
Aware Health

FUNDRAISING

Aware Health aims to deliver the highest ROI to self-insured employers by diagnosing their members without imaging and treating them to resolve their pain without surgery for 95% of the orthopedic cases seen on our virtual platform.
Bilby

Bilby automates regulatory and government analysis using AI and ML to automatically collect data, analyze events, and deliver findings at scale in forms ranging from APIs to reports.
BIOWEG

FUNDRAISING

BIOWEG leverages synthetic biology, materials science, and green chemistry to develop new bio-based ingredients that replace microplastics in cosmetics, personal care, and agriculture coatings using a zero-waste circular process.
Calder Biosciences

FUNDRAISING

Calder Biosciences is developing the next-generation of recombinant protein vaccines with its patented 3D-Vaxlock™ technology, driving increased potency and more durable protection against infectious diseases.
Circu Li-ion

FUNDRAISING

Circu Li-ion enables the economical reuse of battery packs by developing automated upcycling solutions using robotics and AI.
Cocoon Bioscience

Cocoon Bioscience produces critical enzymes and proteins using a novel expression system that leverages insect cocoons as natural bioreactors, offering performance and cost advantages over traditional methods.
Cooler Heads

FUNDRAISING

Cooler Heads helps cancer patients manage the side effects of treatment using an FDA-cleared medical device, allowing patients to keep their hair during chemotherapy and providing additional revenue to infusion centers.
DeepKeep

FUNDRAISING

DeepKeep helps large corporations manage risk and protect growth through its proprietary trust, risk and security management (TRiSM) solution, which utilizes generative AI to secure LLMs and computer vision models.
Digip

FUNDRAISING

Digip provides businesses with an automated trademark filing and protection service that streamlines the trademark protection process.
Direct Kinetic Solutions

FUNDRAISING

Direct Kinetic Solutions strives to decarbonize the energy sector using high-energy-density radioisotopes to create self-sustaining, long-lasting power sources that combine the persistence and reliability of a power plant with the convenience and mobility of a battery the size of a stamp.
Eucalyptus Bio

FUNDRAISING

Eucalyptus Bio is enabling the treatment of hundreds of currently unaddressable genetic diseases using its long-range gene editing platform (CRISP-HR) to permanently correct multiple disease causing mutations within an unparalleled genome edit window.
Fire Neural Network

FUNDRAISING

Fire Neural Network uses AI to detect wildfires, processing lightning data gathered by patented ground-based sensors to identify high-risk lightning and probable ignition points. The hotspots are then validated with a proprietary US-made drone.
Fr0ntierX

FUNDRAISING

Fr0ntierX provides intelligent data using blockchain-based software infrastructure to improve business logic.
Gigantor

FUNDRAISING

Gigantor optimizes artificial intelligence performance for edge mobility devices with a multi-patented circuit-generating system for FPGAs and ASICs.
GlyTherix

FUNDRAISING

GlyTherix is a clinical-stage targeted radiotherapy company developing a first-in-class therapeutic antibody to treat solid tumors expressing Glypican-1 (GPC-1), a cell surface target that occurs within many solid tumors including prostate, bladder & pancreatic cancers.
GreenPod Labs

FUNDRAISING

GreenPod Labs is an Agtech startup developing products to extend the shelf life of fruits and vegetables at ambient temperature during transport and storage.
IMNEWRUN

FUNDRAISING

IMNEWRUN is developing a novel blood-brain barrier penetrating antibody platform and therapeutic pipeline for patients with brain-related diseases, starting with Alzheimer's disease.
INAEDIS

INAEDIS aims to disrupt pharmaceutical cold-chain logistics by enabling the thermal stabilization of heat- and freeze-sensitive biologics at room temperature, using a technology that converts liquid biologics into room-temperature stable powders with proprietary dehydration equipment.
InGel Therapeutics

FUNDRAISING

InGel Therapeutics is developing bioengineered cell therapies to bring back light to patients suffering from all forms of retinal degeneration and blindness.
Kanna Health

FUNDRAISING

Kanna Health is a clinical-stage biotech looking to bridge the 'intimacy gap' by developing an on-demand solution for premature ejaculation, for which there is currently no FDA-approved treatment.
Knowtex

Knowtex empowers clinicians with voice AI automated workflows that capture ambient conversation, identify relevant medical information, and immediately generate a pre-filled structured note with billing codes and orders that are ready to upload into electronic health record systems for clinician review.
Kyber Labs

Kyber Labs looks to address the manual labor shortage with a dexterous robotic manipulation platform that is designed from the ground up for AI-based controls using our novel, low-cost artificial muscle fiber actuators that mimic the functionality of human muscle and allow for natural movements that are not feasible with conventional actuation systems.
Maestro AI

FUNDRAISING

Maestro increases development team velocity and alignment by automatically creating status updates, updating documentation, and helping people stay in sync through a generative AI powered platform.
Matrisome Bio

Matrisome Bio is leveraging a new target, the disease-associated extracellular matrix, to develop nanobodies for highly targeted delivery of therapeutic payloads to a range of chronic disease sites, including tumors, metastases, and fibrotic lesions.
Moody Month

FUNDRAISING

Moody Month is a machine learning platform that forecasts daily hormone, mood and symptom changes, and enables brands to create personalized digital experiences for products in the female health and wellness space.
Narrativa

FUNDRAISING

Narrativa provides AI-automation for clinical trial regulatory documentation and data analysis, helping clients reduce the time and cost spent on regulatory documentation.
NeuroVirt Limited

FUNDRAISING

NeuroVirt combines immersive virtual reality and sensor technology with fun, AI-driven games to provide accessible and effective outpatient rehabilitation therapy to patients recovering from strokes and other neurological conditions.
OraLiva

FUNDRAISING

OraLiva is reshaping the future of oral health through early detection with its AI-based, first-in-class, clinically validated oral cancer adjunctive test.
OxiWear

FUNDRAISING

OxiWear helps patients and high-performance athletes avoid hypoxic injury using an ear-wearable pulse oximeter that provides continuous oxygen monitoring and low-oxygen alerts.
Pando Bioscience

FUNDRAISING

Pando Biosciences is a synthetic biology company transforming active pharmaceutical ingredients production by developing high-performance enzymes using Generative AI and its proprietary ultra-high-throughput screening platform, ultimately reducing costs and improving productivity.
Promise Bio

Promise Bio is uncovering new biological insights to advance precision medicine for immune-mediated diseases by performing broad epiproteomic analysis using a proprietary computational platform.
Quanmol Tech

FUNDRAISING

QuanMol Tech is establishing a new standard for in-silico drug discovery with its AI-powered precision drug design platform that determines optimal compounds from structural information over traditional trial-and-error based processes.
Quantum Bridge Technologies

FUNDRAISING

Quantum Bridge Technologies develops and commercializes cryptographic solutions to protect government and enterprise clients against quantum computer attacks.
resistanceBio

FUNDRAISING

resistanceBio is pioneering a new therapeutic modality to overcome cancer drug resistance by mapping how cancer will evolve to resist therapies using billions of cells in long-term evolution.
Rocket Propulsion Systems

FUNDRAISING

Rocket Propulsion Systems manufactures affordable and reusable rocket engines to create space vehicles that dramatically improve the economics of small-satellite launchers, enhancing in-space orbital operations and national security.
Serinus Bio

FUNDRAISING

Serinus Bio is designing precision medicine drugs to overcome cancer treatment resistance with its active-learning AI platform. The platform also uncovers market opportunities by identifying shared vulnerabilities across resistant patient populations that are otherwise too small or insular to motivate drug development programs.
Sinovia Technologies

FUNDRAISING

Sinovia manufactures flexible OLED indicator and information displays for smart products using traditional newspaper printing techniques and a proprietary materials technology.
SleepScore Labs

FUNDRAISING

SleepScore Labs delivers advanced sleep science data that enables organizations across industries to develop products and services to effectively improve sleep.
Soliyarn

FUNDRAISING

Soliyarn creates smart fabrics sustainably, using a variety of functional coatings that are applied with a proprietary chemical vapor deposition process (CVD). The process preserves the innate characteristics of the fabric and eliminates the use of water in the finishing processes.
Strayos

FUNDRAISING

Strayos helps mining and cement companies sustainably extract raw minerals and reduce waste by applying visual sensing technology and AI-powered software to each step of the mining value chain.
SURF Security

FUNDRAISING

SURF provides secure, productive, and agile browsing experiences for organizations by consolidating multiple endpoint security tools using the SURF Zero-Trust Browser that securely connects users to their web apps.
Synapbox

FUNDRAISING

Synapbox improves brand engagement by leveraging cameras and AI to scale customer interviews, providing fast actionable insights to optimize ROAS.
Tezcat Biosciences

FUNDRAISING

Tezcat Biosciences is developing a receptor-independent drug delivery technology to provide treatment alternatives for patients harboring RAS-activated cancers.
Vector Bioscience

Vector Bioscience is developing a machine learning supported RNA delivery platform for any existing cargo, enabling precision-targeted delivery to tumors with controlled release, driving improved efficiency and minimized side effects.
VESSL AI

FUNDRAISING

VESSL AI enables high-performance machine learning teams to build, train, and deploy models quickly and at scale by providing end-to-end MLOps infrastructure that automates complex processes and optimizes training.
Vivtex

Vivtex is enabling the development of new oral drugs for medications that currently require painful, inconvenient needle injections using its high-throughput, gut-on-a-chip platform supported by its proprietary AI algorithms and formulations.
Vody

Vody empowers e-commerce companies to boost sales and save costs by enhancing recommendation systems and surfacing relevant content using multimodal ML classification and generative models that harness diverse data sets.
ZORDI

FUNDRAISING

Zordi uses AI and intelligent robots to develop automated greenhouses with the goal of feeding the world with high-quality, sustainably-grown produce. Currently operating two farms in New York and New Jersey.

MISSION

To transform breakthrough science into societal impact. We seek to advance human welfare by supporting founders of science and technology-based startups.

PROGRAM

Founded at New York University’s Stern School of Business, Endless Frontier Labs guides founders through a performance-based mentoring process over the course of nine months. Endless Frontier Labs is open to pre-Series A science and technology startups. The program is suitable for founders from around the world seeking connections to the thriving New York startup ecosystem or U.S. markets. Founders are not required to have a New York University affiliation and do not have to relocate to New York. The program is completely free for participating founders and does not take any equity in startups.

PARTNERS

EFL is supported by the program’s Founding Partners Elizabeth Elting, Stan Moss, and Glenn Krevlin. EFL’s corporate partners support the program and its participating startups through a variety of services.